INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
As an autoimmune condition known as type 1 diabetes, your body assaults and kills the cells that produce insulin. This review focuses on the present state and potential applications of gene therapy in the treatment of T1DM. Gene therapy is one possible therapeutic option. The majority of studies that are presented on gene therapy for the treatment of T1DM use animal models and preclinical research. However, the efficacy of these treatments in humans has not yet been proven. Several gene-based treatments are now under investigation, including genetic vaccines, immune precursor cells, or vectors, transplanting cells that express certain genes, delivering gene therapy through stem cells, and overexpressing the genes and proteins necessary to combat T1D.
Keywords:
Diabetes, Gene therapy, Insulin.
Cite Article:
"GENE THERAPY FOR DIABETES MELLITUS TYPE 1", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 2, page no.b168-b173, February-2023, Available :http://www.ijnrd.org/papers/IJNRD2302119.pdf
Downloads:
000118746
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn